Home Biosimilar Antibodies Others Others antibody Citatuzumab (Anti-EpCAM / TROP1 / CD326) For research use only.
Not for use in humans.

Citatuzumab (Anti-EpCAM / TROP1 / CD326)

Synonyms: VB6-845

Citatuzumab (Anti-EpCAM / TROP1 / CD326) is a recombinant immunotoxin that composed of humanized monoclonal antibody targeting EpCAM. It has antitumor activity and can be used in treatment of cancer. MW :145.4 KD.

Citatuzumab (Anti-EpCAM / TROP1 / CD326)

Purity & Quality Control

≥99

Biological Activity

Description Citatuzumab (Anti-EpCAM / TROP1 / CD326) is a recombinant immunotoxin that composed of humanized monoclonal antibody targeting EpCAM. It has antitumor activity and can be used in treatment of cancer. MW :145.4 KD.

Product Details

CAS No. 945228-49-9
Molecular Weight 145.4
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Citatuzumab (Anti-EpCAM / TROP1 / CD326) | Citatuzumab (Anti-EpCAM / TROP1 / CD326) supplier | purchase Citatuzumab (Anti-EpCAM / TROP1 / CD326) | Citatuzumab (Anti-EpCAM / TROP1 / CD326) cost | Citatuzumab (Anti-EpCAM / TROP1 / CD326) manufacturer | order Citatuzumab (Anti-EpCAM / TROP1 / CD326) | Citatuzumab (Anti-EpCAM / TROP1 / CD326) distributor